IMV Inc. (IMVIF)
OTCMKTS · Delayed Price · Currency is USD
0.0195
+0.0195 (1,949,900.00%)
At close: Sep 30, 2025
IMV Inc. Market Cap
IMV Inc. has a market cap or net worth of $286.88 thousand as of October 15, 2025. Its market cap has decreased by -98.88% in one year.
Market Cap
286.88K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since May 25, 2012, IMV Inc.'s market cap has decreased from 17.18M to 286.88K, a decrease of -98.33%. That is a compound annual growth rate of -26.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 286.88K | 1,912,413.33% |
| Dec 30, 2024 | 15.00 | -99.94% |
| Dec 29, 2023 | 25.77K | -99.92% |
| Dec 30, 2022 | 30.60M | -69.46% |
| Dec 31, 2021 | 100.21M | -51.51% |
| Dec 31, 2020 | 206.65M | 40.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 694.90M |
| Elite Pharmaceuticals | 673.15M |
| Veradigm | 517.28M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 356.04M |
| CytoDyn | 334.34M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 259.79M |